Altoida Celebrates Historic Day for Patients with Alzheimer’s Disease

About Altoida

We’re pioneering precision neurology by building the world’s leading platform for reliable, accessible, affordable diagnosis and monitoring of neurological diseases.

Our Story

“My grandmother was born in a small village in Greece. When she was 70 and I was pursuing my degree in psychology, she started to repeat her own words. Soon after, she started to become lost in her home, the place that she loved most. In the later stages of what we knew to be Alzheimer’s, she started to forget my father’s face. What struck me most was how in the early stages, I was able to recognize that something was wrong, yet she passed all of the traditional cognitive exams with ease.

This drove me to engineer a virtual environment to assess the changes in brain health, both cognitive and functional, that I observed firsthand with my grandmother. I learned that exercises in a virtual environment open up an entirely new horizon of more meaningful measurements and data that can be acquired. From there, we spent 20 years of research to bring us to where we are today.”

- Ioannis Tarnanas, Ph.D. - Co-Founder and Chief Scientific Officer (CSO)

Our Growth

Early Scientific Research

Active digital biomarkers provide a new understanding of neurocognitive function.

2001-2014

First Validation Study

Five-year study on Altoida's simulation of ADL's to predict Alzheimer's conversions.

Nov 2015

EIT Innovators Award

Dr. Tarnanas presents Altoida at TedX in Zurich; goes on to win EIT Innovators Award 2018.

Oct 2018

Second Validation Study

Four-year study validating Altoida's 94% diagnostic accuracy for AD.

Dec 2020

Nature Publication

Critical publication shows Altoida is the most sensitive measurement device.

June 2021

FDA Breakthrough

Altoida's Breakthrough designation pioneers Precision Neurology.

July 2021

Revolutionizing Brain Health

Today, our augmented reality platform delivers robust measurements of cognitive and functional brain health across 13 unique neurocognitive domains. Tomorrow, our platform and innovative artificial intelligence will power early Alzheimer’s disease identification.
explore our technology

Discover Your Path to Better Brain Health

At Altoida, we provide digital biomarker technology that allows you to understand your brain health early to take the right next steps. Connect with our team today.
CONNECT WITH US

Contact Us

80 M Street SE, Suite 100 Washington, DC 20003 USA 

CONTACT@ALTOIDA.COM

Follow Us

Policy

By visiting our Website and/or using the Services in any manner, you acknowledge that you accept the practices and policies outlined in our Privacy Policy.


Our Disclaimer

@ Altoida 2022